Dotmatics collaborates with LabVoice Kumar Jeetendra | November 14, 2020 Dotmatics Ltd, a scientific informatics software and services company that is driving the automation of laboratory data workflows for scientific discovery and innovation research, today announced a new partnership with LabVoice to provide R&D scientists with the ability to record, access, and track data within an electronic laboratory notebook (ELN) using hands-free voice-assisted technology. The …
Antibiotics directed before age 2 are connected to ongoing conditions Kumar Jeetendra | November 16, 2020 In a retrospective case study, Mayo Clinic researchers have found that antibiotics administered to children younger than 2 are associated with several ongoing illnesses or ailments, which range from allergies to obesity. The findings appear in Mayo Clinic Proceedings. Using health record data from the Rochester Epidemiology Project, a population-based research cooperation in Minnesota and …
Polypill in addition to headache medicine and polypill alone reduced cardiovascular sickness hazard Kumar Jeetendra | November 17, 2020 A single, daily pill combining blood pressure and cholesterol medications, as well as the addition of a daily dose of aspirin, reduced cardiovascular disease events in people at risk for heart disease, according to late-breaking study presented today in a late-breaking clinical trial presentation at the American Heart Association’s Scientific Sessions 2020. The virtual conference, …
Patients’ own stem cells can be utilized to develop new bones, study shows Kumar Jeetendra | November 23, 2020 A new, groundbreaking study from the University of Bergen (UiB) shows that a patients’ own stem cells can be used to grow new bone. This can potentially help millions of people who are partially edentulous and have inadequate bone for placement of dental implants. The Maxibone Project, coordinated by Pierre Layrolle, Inserm, University of Nantes, …
University of Sheffield and Pfizer dispatch new consortium to quicken improvement of ATMPs Kumar Jeetendra | November 24, 2020 The University of Sheffield and Pfizer have today (23 November 2020) established a new consortium which aims to standardize and accelerate the growth of Advanced Therapy Medicinal Products (ATMPs), allowing potentially transformative remedies to reach patients sooner. The new, five-year consortium, Accelerating Research and Innovation for Advanced Therapies (ARDAT), is supported by the Innovative Medicines …
Study uncovers a quality answerable for anthraquinone synthesis in plants Kumar Jeetendra | November 25, 2020 Anthraquinones are a class of naturally occurring chemicals prized for their medicinal properties, as well as for other programs, including ecologically friendly dyes. Despite broad interest, the mechanism by which plants produce them has remained shrouded in mystery until today. New work from an international group of scientists including Carnegie’s Sue Rhee shows a gene …
Dexamethasone use could reduce immune checkpoint inhibitor viability in glioblastoma patients Kumar Jeetendra | November 25, 2020 Bottom Line: One of patients with glioblastoma getting an immune checkpoint inhibitor, people who obtained the corticosteroid dexamethasone at baseline for cerebral edema had significantly worse overall survival. Journal Where the Study was Released: Clinical Cancer Research, a journal of the American Association for Cancer Research Author: David A. Reardon, MD, clinical director of the …
Researchers grow first plant-based gel to help organoid development for biomedical applications Kumar Jeetendra | November 26, 2020 Monash University researchers have created the world’s first bioactive plant-based nanocellulose hydrogel to support organoid growth and help significantly reduce the costs of research into cancer and COVID-19. This discovery by researchers in BioPRIA (Bioresource Processing Institute of Australia), Monash University’s Department of Chemical Engineering and the Monash Biomedicine Discovery Institute will develop organoids cheaper, …
Researchers distinguish systems behind inflammasome initiation by fungal pathogens Kumar Jeetendra | December 3, 2020 Researchers at St. Jude Children’s Research Hospital have identified the mechanisms behind inflammasome activation driven by infection with the fungal pathogen Aspergillus fumigatus. Fungal infection, especially with A. fumigatus, is a leading cause of infection-associated deaths in people with compromised immune systems. The work provides clues to a potential therapeutic approach for treating infectious and …
ATCC presents new product with launch of SARS-CoV-2 external control unit Kumar Jeetendra | December 4, 2020 The ready-to-run kit provides controls in the rapidly changing COVID-19 testing landscape as a workflow-optimized kit with complete genome coverage that is widely compatible with most commercial and laboratory-developed tests. Federal regulation requires that clinical laboratories assess the performance of their testing applications. This new ATCC kit is a practical, kitted solution clinical laboratories can …
Free radicals might be significant for the brain to stay versatile Kumar Jeetendra | December 6, 2020 Reactive oxygen molecules, also known as”free radicals”, are generally considered dangerous. Researchers from the German Center for Neurodegenerative Diseases (DZNE) and the Center for Regenerative Therapies Dresden (CRTD) at TU Dresden published the findings in the journal Cell Stem Cell. The researchers focused on the”hippocampus”, a brain region that is regarded as the control center …
CRISPR-based test could give fast, affordable testing to help control COVID-19 spread Kumar Jeetendra | December 7, 2020 Imagine swabbing your nostrils, putting the swab in a device, and obtaining a read-out on your mobile phone in 15 to 30 minutes which tells you if you’re infected with the COVID-19 virus. This has been the vision for a group of scientists at Gladstone Institutes, University of California, Berkeley (UC Berkeley), and University of …
